新开源 (300109)
NKY Medical Holdings Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 48605.00
- Circulating A-Shares(W): 44968.85
- Earnings Per Share(RMB): 0.4100
- Net Assets Per Share(RMB): 7.6580
- Operating Revenue(W RMB): 95149.95
- Total Profit(W RMB): 24711.28
- Net Profit Attributable to Parent(W RMB): 20108.81
- Net Profit Growth Rate(%): -35.39
- Weighted Return on Equity(%): 5.4200
- Operating Cash Flow Per Share(RMB): 0.4400
- Undistributed Profit Per Share(RMB): 2.1037
- Capital Reserve Per Share(RMB): 4.2107
2. Main Business
The main business covers:
- Fine Chemicals
- Precision Medicine
3. Company Basic Information
- Company Name: Boai NKY Medical Holdings Ltd.
- Listing Date: 2010-08-25
- Industry: Chemicals - Chemical Products
- Address: No. 1888, East Section of Wenhua Road, Boai County, Jiaozuo City, Henan Province, China
- Website: www.boai-nky.com
- Company Profile: The company was established by the overall change of all shareholders of the former NKY Co., Ltd. On April 25, 2009, the shareholders' meeting resolved to convert the audited net assets of 43.9719 million yuan as of December 31, 2008, into 27 million shares at a ratio of 1:0.614, with the remaining 16.9719 million yuan recorded as capital reserve. On May 18, 2009, the Jiaozuo Administration for Market Regulation issued the business license with registration number 410822100001782.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Wuhu Changcheng Guolong Investment Management Co., Ltd. - Wuhu Changqian Investment Center (Limited Partnership) | General Legal Person | 1394.04 | 3.10 |
5. Concept Sectors
- Gene Concept
- Immunotherapy
- Solid-State Battery
- Innovative Drugs
- AI Healthcare
- Margin Trading & Securities Lending
- Dispersed Shareholding
- Intended Reduction
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information